These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 19049481)

  • 21. High-dose furosemide for established ARF: a prospective, randomized, double-blind, placebo-controlled, multicenter trial.
    Cantarovich F; Rangoonwala B; Lorenz H; Verho M; Esnault VL;
    Am J Kidney Dis; 2004 Sep; 44(3):402-9. PubMed ID: 15332212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: a double-blind placebo-controlled pilot study.
    Chen HH; Sundt TM; Cook DJ; Heublein DM; Burnett JC
    Circulation; 2007 Sep; 116(11 Suppl):I134-8. PubMed ID: 17846293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients.
    Brienza N; Malcangi V; Dalfino L; Trerotoli P; Guagliardi C; Bortone D; Faconda G; Ribezzi M; Ancona G; Bruno F; Fiore T
    Crit Care Med; 2006 Mar; 34(3):707-14. PubMed ID: 16505657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ; Taylor KP; Ashby MJ; Brown MJ
    Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial.
    Gheorghiade M; Niazi I; Ouyang J; Czerwiec F; Kambayashi J; Zampino M; Orlandi C;
    Circulation; 2003 Jun; 107(21):2690-6. PubMed ID: 12742979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors predicting hyperkalemia in patients with cirrhosis receiving spironolactone.
    Abbas Z; Mumtaz K; Salam A; Jafri W
    J Coll Physicians Surg Pak; 2003 Jul; 13(7):382-4. PubMed ID: 12887837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial.
    Matthesen SK; Larsen T; Vase H; Lauridsen TG; Jensen JM; Pedersen EB
    Clin Exp Hypertens; 2013; 35(5):313-24. PubMed ID: 22966789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized, double-blind, placebo-controlled crossover pilot study of a potassium channel blocker in patients with septic shock.
    Warrillow S; Egi M; Bellomo R
    Crit Care Med; 2006 Apr; 34(4):980-5. PubMed ID: 16484892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is continuous infusion ceftriaxone better than once-a-day dosing in intensive care? A randomized controlled pilot study.
    Roberts JA; Boots R; Rickard CM; Thomas P; Quinn J; Roberts DM; Richards B; Lipman J
    J Antimicrob Chemother; 2007 Feb; 59(2):285-91. PubMed ID: 17135183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcomes of a furosemide infusion protocol in edematous patients in the intensive care unit.
    Thomsen G; Bezdjian L; Rodriguez L; Hopkins RO
    Crit Care Nurse; 2012 Dec; 32(6):25-34. PubMed ID: 23203952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure.
    Pivac N; Rumboldt Z; Sardelić S; Bagatin J; Polić S; Ljutić D; Naranca M; Capkun V
    Int J Clin Pharmacol Res; 1998; 18(3):121-8. PubMed ID: 9825268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of postoperative intravenous loop diuretic on renal function after major surgery.
    Hager B; Betschart M; Krapf R
    Schweiz Med Wochenschr; 1996 Apr; 126(16):666-73. PubMed ID: 8658094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion.
    Dormans TP; van Meyel JJ; Gerlag PG; Tan Y; Russel FG; Smits P
    J Am Coll Cardiol; 1996 Aug; 28(2):376-82. PubMed ID: 8800113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
    Cho HS; Park GT; Kim YH; Shim SG; Kim JB; Lee OY; Choi HS; Hahm JS; Lee MH
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of human atrial natriuretic peptide on renal function in patients undergoing abdominal aortic aneurysm repair.
    Mitaka C; Kudo T; Jibiki M; Sugano N; Inoue Y; Makita K; Imai T
    Crit Care Med; 2008 Mar; 36(3):745-51. PubMed ID: 18431264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypernatraemia in critically ill patients: too little water and too much salt.
    Hoorn EJ; Betjes MG; Weigel J; Zietse R
    Nephrol Dial Transplant; 2008 May; 23(5):1562-8. PubMed ID: 18065827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study on safety and efficacy of concentrated potassium chloride infusions in critically ill patients with hypokalemia].
    He Q; Wang JH; Liu YL; Tang PX; Chang ZG; Du LQ; Huang XF
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Jul; 20(7):416-8. PubMed ID: 18611341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
    Paterna S; Di Pasquale P; Parrinello G; Amato P; Cardinale A; Follone G; Giubilato A; Licata G
    Eur J Heart Fail; 2000 Sep; 2(3):305-13. PubMed ID: 10938493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.